GSA CAPITAL PARTNERS LLP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$762
+173.1%
568,298
+591.7%
0.06%
+85.7%
Q4 2022$279
-100.0%
82,162
-57.2%
0.04%
-77.4%
Q4 2021$1,234,000
+19.8%
191,976
+8.5%
0.16%
+47.6%
Q3 2021$1,030,000
+242.2%
176,996
+507.4%
0.10%
+208.8%
Q2 2021$301,000
-6.5%
29,138
-4.8%
0.03%
-35.8%
Q1 2021$322,000
-5.0%
30,592
+39.7%
0.05%
-3.6%
Q4 2020$339,00021,9030.06%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders